BioGaia AB (publ) (BIOG-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) has a cash flow conversion efficiency ratio of 0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr70.36 Million ≈ $7.57 Million USD) by net assets (Skr1.40 Billion ≈ $150.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BioGaia AB (publ) (BIOG-B) balance sheet quality index to measure how much of total assets are equity-financed.
BioGaia AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how BioGaia AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is BioGaia AB (publ)'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
BioGaia AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioGaia AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jupiter Wagons Limited
NSE:JWL
|
-0.041x |
|
Suofeiya Home Collection Co Ltd
SHE:002572
|
-0.038x |
|
Tongyang Inc
KO:001525
|
-0.001x |
|
Americas Silver Corp
TO:USA
|
-0.213x |
|
Bolsa Mexicana de Valores S.A.B. de C.V
MX:BOLSAA
|
0.042x |
|
Carlsberg Brewery Malaysia Bhd
KLSE:2836
|
0.636x |
|
Anadolu Anonim Turk Sigorta Sti
IS:ANSGR
|
0.069x |
|
Batisoke Soke Cimento Sanayi TAS
IS:BSOKE
|
0.033x |
Annual Cash Flow Conversion Efficiency for BioGaia AB (publ) (2002–2025)
The table below shows the annual cash flow conversion efficiency of BioGaia AB (publ) from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see BioGaia AB (publ) stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.31 Billion ≈ $141.43 Million |
Skr306.57 Million ≈ $32.99 Million |
0.233x | +7.75% |
| 2024-12-31 | Skr1.72 Billion ≈ $185.52 Million |
Skr373.22 Million ≈ $40.16 Million |
0.216x | +3.19% |
| 2023-12-31 | Skr2.03 Billion ≈ $218.50 Million |
Skr425.96 Million ≈ $45.84 Million |
0.210x | +29.74% |
| 2022-12-31 | Skr1.97 Billion ≈ $212.26 Million |
Skr318.94 Million ≈ $34.32 Million |
0.162x | +36.82% |
| 2021-12-31 | Skr1.88 Billion ≈ $202.03 Million |
Skr221.88 Million ≈ $23.88 Million |
0.118x | -6.72% |
| 2020-12-31 | Skr1.75 Billion ≈ $187.92 Million |
Skr221.26 Million ≈ $23.81 Million |
0.127x | -56.48% |
| 2019-12-31 | Skr507.87 Million ≈ $54.66 Million |
Skr147.85 Million ≈ $15.91 Million |
0.291x | -19.22% |
| 2018-12-31 | Skr508.12 Million ≈ $54.68 Million |
Skr183.12 Million ≈ $19.71 Million |
0.360x | -24.90% |
| 2017-12-31 | Skr463.89 Million ≈ $49.92 Million |
Skr222.62 Million ≈ $23.96 Million |
0.480x | +34.69% |
| 2016-12-31 | Skr415.18 Million ≈ $44.68 Million |
Skr147.93 Million ≈ $15.92 Million |
0.356x | +20.03% |
| 2015-12-31 | Skr395.83 Million ≈ $42.60 Million |
Skr117.50 Million ≈ $12.64 Million |
0.297x | -17.76% |
| 2014-12-31 | Skr344.59 Million ≈ $37.08 Million |
Skr124.38 Million ≈ $13.39 Million |
0.361x | +45.81% |
| 2013-12-31 | Skr316.86 Million ≈ $34.10 Million |
Skr78.44 Million ≈ $8.44 Million |
0.248x | -66.30% |
| 2012-12-31 | Skr456.79 Million ≈ $49.16 Million |
Skr335.56 Million ≈ $36.11 Million |
0.735x | +132.47% |
| 2011-12-31 | Skr230.35 Million ≈ $24.79 Million |
Skr72.79 Million ≈ $7.83 Million |
0.316x | -14.17% |
| 2010-12-31 | Skr187.32 Million ≈ $20.16 Million |
Skr68.97 Million ≈ $7.42 Million |
0.368x | +11.31% |
| 2009-12-31 | Skr161.12 Million ≈ $17.34 Million |
Skr53.29 Million ≈ $5.73 Million |
0.331x | +128.07% |
| 2008-12-31 | Skr132.42 Million ≈ $14.25 Million |
Skr19.20 Million ≈ $2.07 Million |
0.145x | +170.52% |
| 2007-12-31 | Skr94.91 Million ≈ $10.21 Million |
Skr5.09 Million ≈ $547.55K |
0.054x | +580.80% |
| 2006-12-31 | Skr74.53 Million ≈ $8.02 Million |
Skr-831.00K ≈ $-89.43K |
-0.011x | +91.97% |
| 2005-12-31 | Skr71.78 Million ≈ $7.72 Million |
Skr-9.97 Million ≈ $-1.07 Million |
-0.139x | -155.28% |
| 2004-12-31 | Skr91.50 Million ≈ $9.85 Million |
Skr22.99 Million ≈ $2.47 Million |
0.251x | +27.74% |
| 2003-12-31 | Skr114.85 Million ≈ $12.36 Million |
Skr22.59 Million ≈ $2.43 Million |
0.197x | -14.88% |
| 2002-12-31 | Skr127.99 Million ≈ $13.77 Million |
Skr29.57 Million ≈ $3.18 Million |
0.231x | -- |
About BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more